<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_hTVu6mJ">The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2012-04-25">25 April 2012</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Marcia</forename><surname>Vervloet</surname></persName>
							<email>m.vervloet@nivel.nl</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> NIVEL , Netherlands Institute for Health Services Research , Utrecht , The Netherlands</note>
								<orgName type="institution" key="instit1">NIVEL</orgName>
								<orgName type="institution" key="instit2">Netherlands Institute for Health Services Research</orgName>
								<address>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Annemiek</forename><forename type="middle">J</forename><surname>Linn</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Amsterdam School of Communication Research (ASCoR) , University of Amsterdam , Amsterdam , The Netherlands</note>
								<orgName type="department">Amsterdam School of Communication Research (ASCoR)</orgName>
								<orgName type="institution">University of Amsterdam</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Julia</forename><forename type="middle">C M</forename><surname>Van Weert</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Amsterdam School of Communication Research (ASCoR) , University of Amsterdam , Amsterdam , The Netherlands</note>
								<orgName type="department">Amsterdam School of Communication Research (ASCoR)</orgName>
								<orgName type="institution">University of Amsterdam</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dinny</forename><forename type="middle">H</forename><surname>De Bakker</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> NIVEL , Netherlands Institute for Health Services Research , Utrecht , The Netherlands</note>
								<orgName type="institution" key="instit1">NIVEL</orgName>
								<orgName type="institution" key="instit2">Netherlands Institute for Health Services Research</orgName>
								<address>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Tranzo , Scientific Centre for Care and Welfare , Tilburg University , Tilburg , The Netherlands</note>
								<orgName type="department" key="dep1">Tranzo</orgName>
								<orgName type="department" key="dep2">Scientific Centre for Care and Welfare</orgName>
								<orgName type="institution">Tilburg University</orgName>
								<address>
									<settlement>Tilburg</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marcel</forename><forename type="middle">L</forename><surname>Bouvy</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Utrecht Institute for Pharmaceutical Sciences (UIPS) , Division of Pharmacoepidemiology and Clinical Pharmacology , Utrecht University , Utrecht , The Netherlands</note>
								<orgName type="department">Division of Pharmacoepidemiology and Clinical Pharmacology</orgName>
								<orgName type="institution" key="instit1">Utrecht Institute for Pharmaceutical Sciences (UIPS)</orgName>
								<orgName type="institution" key="instit2">Utrecht University</orgName>
								<address>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Liset</forename><surname>Van Dijk</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> NIVEL , Netherlands Institute for Health Services Research , Utrecht , The Netherlands</note>
								<orgName type="institution" key="instit1">NIVEL</orgName>
								<orgName type="institution" key="instit2">Netherlands Institute for Health Services Research</orgName>
								<address>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<note type="raw_affiliation">NIVEL , Netherlands Institute for Health Services Research , PO Box 1568 , 3500 BN Utrecht , The Netherlands ;</note>
								<orgName type="institution" key="instit1">NIVEL</orgName>
								<orgName type="institution" key="instit2">Netherlands Institute for Health Services Research</orgName>
								<address>
									<postBox>PO Box 1568</postBox>
									<postCode>3500 BN</postCode>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_hFxJxvE">The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2012-04-25">25 April 2012</date>
						</imprint>
					</monogr>
					<idno type="MD5">39D9585EF88EF3BD370D2FDF0808272B</idno>
					<idno type="DOI">10.1136/amiajnl-2011-000748).</idno>
					<note type="submission">Received 2 December 2011 Accepted 13 March 2012</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T06:47+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_rEFQheh"><p xml:id="_AZ2w2G7"><s xml:id="_NbdGgVA">Background Many patients experience difficulties in adhering to long-term treatment.</s><s xml:id="_d4bHqBJ">Although patients' reasons for not being adherent are diverse, one of the most commonly reported barriers is forgetfulness.</s><s xml:id="_BrzVwDq">Reminding patients to take their medication may provide a solution.</s><s xml:id="_28fAWsH">Electronic reminders (automatically sent reminders without personal contact between the healthcare provider and patient) are now increasingly being used in the effort to improve adherence.</s><s xml:id="_GBPcW8D">Objective To examine the effectiveness of interventions using electronic reminders in improving patients' adherence to chronic medication.</s><s xml:id="_uTtw5UG">Methods A comprehensive literature search was conducted in PubMed, Embase, PsycINFO, CINAHL and Cochrane Central Register of Controlled Trials.</s><s xml:id="_a6WTPVU">Electronic searches were supplemented by manual searching of reference lists and reviews.</s><s xml:id="_AaJcZgk">Two reviewers independently screened all citations.</s><s xml:id="_Mr8CXs5">Full text was obtained from selected citations and screened for final inclusion.</s><s xml:id="_y3Hv4UT">The methodological quality of studies was assessed.</s></p><p xml:id="_7VCpT4y"><s xml:id="_Kv3BXN9">Results Thirteen studies met the inclusion criteria.</s><s xml:id="_kshtVGM">Four studies evaluated short message service (SMS) reminders, seven audiovisual reminders from electronic reminder devices (ERD), and two pager messages.</s><s xml:id="_B2m4va4">Best evidence synthesis revealed evidence for the effectiveness of electronic reminders, provided by eight (four high, four low quality) studies showing significant effects on patients' adherence, seven of which measured short-term effects (follow-up period &lt;6 months).</s><s xml:id="_RKWTucf">Improved adherence was found in all but one study using SMS reminders, four studies using ERD and one pager intervention.</s><s xml:id="_AbrdRtZ">In addition, one high quality study using an ERD found subgroup effects.</s><s xml:id="_U2RQg5b">Conclusion This review provides evidence for the shortterm effectiveness of electronic reminders, especially SMS reminders.</s><s xml:id="_SDHwSDN">However, long-term effects remain unclear.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_b3K7E6t"><p xml:id="_8GUBWkQ"><s xml:id="_Bj8Q6PJ">Adherence is the extent to which a person's behaviordtaking medication and/or executing lifestyle changesdcorresponds with agreed recommendations from a healthcare provider. <ref type="bibr" target="#b0">1</ref></s><s xml:id="_nH8PAHJ">Many patients, especially those with chronic illnesses, experience difficulties in adhering to prescribed treatment.</s><s xml:id="_ARfnteG">Average adherence rates to long-term treatment are low. <ref type="bibr">1 2</ref> Poor adherence compromises the effectiveness of medication treatment and results in suboptimal illness control.</s><s xml:id="_BvKCUsh">This can lead to increased use of healthcare services, reduction in patients' quality of life, and increased healthcare costs.</s><s xml:id="_TjbWHUU"><ref type="bibr">3e5</ref> Numerous interventions aimed at improving adherence have been conducted, but these were mostly complex and not very effective. <ref type="bibr" target="#b5">6</ref></s><s xml:id="_xkWaTdG">omplex interventions are often time consuming, labor intensive and costly, thus not feasible in busy clinical practice.</s><s xml:id="_ZzP4uVK">According to experts in the field of adherence, simple interventions, ie, interventions that are workable in daily practice and that are easy for both professional and patient, appear to be most promising in furthering patients' adherence. <ref type="bibr" target="#b6">7</ref></s><s xml:id="_AzTBQra">An example of a simple intervention is reminding patients of their medication intake.</s><s xml:id="_Pz64TtV">Reminders can especially provide a solution for patients who are unintentionally non-adherent, ie, patients who are willing to take their medication but forget it or are inaccurate with their timing. <ref type="bibr" target="#b7">8</ref></s><s xml:id="_8GjszW3">Forgetfulness is commonly reported as a barrier to adherence in various patient populations.</s><s xml:id="_N35kJY3"><ref type="bibr">9e18</ref> Albeit the range of patients reporting this barrier varies from 22% to 73% across the studies, in all studies forgetting to take a dose was the most frequently cited reason for non-adherence.</s></p><p xml:id="_VcHKQJQ"><s xml:id="_sNQmfep">Two reviews on the effectiveness of 'reminder packaging', which refers to any medication package (eg, a pill box, blister package, bottle) that physically incorporates a system for the day and/or time for medication to be taken, reported modest improvements in adherence to long-term medications. <ref type="bibr">19 20</ref></s><s xml:id="_jwH4UzA">However, patients are not actively reminded with this type of packaging.</s><s xml:id="_Jh7HRW5">Studies evaluating the effect of personaldand thus actived reminders, such as telephone calls or emails from healthcare providers to patients, revealed positive effects on adherence rates. <ref type="bibr">21 22</ref></s><s xml:id="_rHuVxVh">However, personal reminders can require an extensive time investment from healthcare providers.</s><s xml:id="_ZPrUZsF">Electronic reminders, on the contrary, are automatically sent to patients at the appropriate time without interference of a healthcare provider.</s><s xml:id="_BDxgQAf">Examples are reminder messages automatically sent to a patient's mobile phone with a short message service (SMS), an electronic reminder device (ERD) that provides patients with an audio and/or visual reminder at predetermined times, or text messages sent to patients' pager to alert them of their medication.</s><s xml:id="_EPvGEEp">This type of reminding does not require additional effort from professionals and may be easy to integrate in patients' daily life.</s></p><p xml:id="_hA8PSQ6"><s xml:id="_Jtwc6fC">Interventions using reminders are primarily based on the principles of behavioral learning theory. <ref type="bibr" target="#b22">23</ref></s><s xml:id="_KXHHw3h">ccording to this theory, behavior depends on stimuli or cues, either internal (thoughts) or external (environmental cues), suggesting that non-adherent behavior can be modified after sufficient repetition of external stimuli or cues such as reminders.</s></p><p xml:id="_Hbp3266"><s xml:id="_qTb96r4">With the increasing use of electronic reminders aimed at improving medication adherence, there is a need to gain insight into the effects of this type of reminding.</s><s xml:id="_4YKTgTg">Previous reviews evaluating strategies for improving adherence among which electronic reminders often focused on specific patient populations.</s><s xml:id="_fzxRkTg">For example, Gray et al <ref type="bibr" target="#b23">24</ref> found that a reminder device might be beneficial to patients with glaucoma.</s><s xml:id="_F2T4ZNm">Wise and Operario <ref type="bibr" target="#b24">25</ref> showed that half of the studies included in their review reported significantly improved adherence in HIV patients as a result of ERD.</s><s xml:id="_nh5z3nd">Misono et al <ref type="bibr" target="#b25">26</ref> reviewed studies using healthcare information technology interventions to improve adherence to cardiovascular and diabetes medication, and showed that of these interventions, reminder systems provided the best evidence for increasing adherence.</s><s xml:id="_peS5yCZ">To our knowledge, no review has been conducted that systematically studied the effects of specifically electronic reminding (eg, via SMS, ERD, pager/beeper systems) on patients' adherence to a range of long-term medication.</s><s xml:id="_Vy4DNqD">Therefore, in this systematic review, we aim to synthesize and critically appraise the existing evidence on the effectiveness of electronic reminders in improving patients' adherence to chronic medication.</s><s xml:id="_ECbuxyN">In addition, we aim to investigate the characteristics of electronic reminders that are associated with their effectiveness.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_yZpymUM">METHODS</head><p xml:id="_6AA2nut"><s xml:id="_gJE4UGU">This review was conducted according to the guidelines of the Cochrane Collaboration described in the Cochrane handbook for systematic reviews of interventions, version 5.1.0</s><s xml:id="_9Mc2HmT">(updated March 2011). <ref type="bibr" target="#b26">27</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NtnarXK">Inclusion criteria</head><p xml:id="_3ySuAN6"><s xml:id="_AC2a5cP">A study was included in this review if it met the following inclusion criteria: (1) the intervention was aimed at patients who were prescribed chronic medication; (2) the intervention involved an electronic reminder aimed at improving medication adherence; (3) the reminder was directed to the patient; (4) one of the outcome measures was medication adherence; (5) the study design was either a randomized controlled trial (RCT) or a controlled clinical trial (CCT); (6) the study was published in English.</s><s xml:id="_CGjV4Df">Studies using historical controls were excluded, as possible bias may be introduced due to factors (other than the intervention) that may have changed over time.</s></p><p xml:id="_kMhzfGN"><s xml:id="_9CUhcuv">We defined an electronic reminder as an automatically sent reminder without personal contact between healthcare provider and patient.</s><s xml:id="_M48CPUN">Consequently, telephone calls, emails or SMS personally sent by healthcare providers were excluded.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_suJZaf9">Search strategy</head><p xml:id="_mAcazaV"><s xml:id="_GRgQ2B4">We conducted a comprehensive literature search in PubMed, Embase, PsycINFO, CINAHL and the Cochrane Central Register of Controlled Trials.</s><s xml:id="_YBpArrf">We used the following MeSH terms and keywords for searching PubMed: (medication adherence OR patient compliance OR medication therapy management) AND (cellular phone OR reminder systems OR text message OR electronic reminder) AND (intervention study OR randomized controlled trial OR controlled clinical trial).</s><s xml:id="_BtQg2NK">Advanced search, allowing for explosion search, mapping to preferred terminology, searching keywords or in all text was used in the other databases whenever possible.</s><s xml:id="_x6nftVk">No restriction on publication date was applied.</s><s xml:id="_GCmDHYG">The electronic databases were last searched on 7 March 2011.</s><s xml:id="_Wn9xWp5">Electronic searches were supplemented by manual searching of reference lists of relevant reviews ('snowball method').</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_X3qSjtB">Review procedures</head><p xml:id="_BpBpnG3"><s xml:id="_GvFweAP">Reference Manager 11.0 was used to manage all citations.</s><s xml:id="_BYPSY3Z">Independently, three reviewers (MV as first reviewer and either AJL or LvD as second reviewer) screened all citations (title and abstract) identified by the electronic and manual searches.</s><s xml:id="_mDWcdBr">Full text was obtained for the potentially eligible studies and for those for which we had insufficient information.</s><s xml:id="_ASJNVuG">The interrater agreement between MV and AJL and MV and LvD was 92% and 97%, respectively.</s><s xml:id="_ZgGHnA7">Full text articles were reviewed independently by AJL and MV for final inclusion in the review according to the inclusion criteria mentioned earlier.</s><s xml:id="_2jSNbJX">Reasons for exclusion of studies at this stage are given in supplementary appendix A (available online only).</s><s xml:id="_edfvvjy">Disagreements between reviewers were resolved by discussion.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Se79h2u">Data extraction</head><p xml:id="_VwTdezp"><s xml:id="_rQNZ6uA">MV extracted the following study characteristics (see table <ref type="table" target="#tab_1">1</ref> and supplementary appendix B, available online only): &lt; General information (first author, year of publication) &lt; Study design &lt; Study population (sample size, age, gender, medication/ disease) &lt; Intervention (description of experiment and control condition, type of reminder) &lt; Adherence measure (type of measurement, follow-up period) &lt; Main study results &lt; Authors' conclusion.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2s4p83Z">Methodological quality</head><p xml:id="_45qFXzg"><s xml:id="_CkGWRWV">The methodological quality of the studies was assessed independently by AJL and MV according to the criteria list from the Cochrane Collaboration Back Review Group. <ref type="bibr" target="#b40">41</ref></s><s xml:id="_nFgWUwB">This list addresses 11 criteria for identifying potential sources of bias: 1. Selection bias (three criteria), referring to systematic differences between participants in the different groups: (a) proper generation of allocation sequence; (b) proper concealment of treatment allocation; and (c) comparability of groups at baseline.</s><s xml:id="_3UrmKNY">2. Performance bias (four criteria), referring to systematic differences between the groups in the care provided to participants, apart from the intervention that is evaluated: (d) participants kept blind to treatment allocation; (e) care providers kept blind to treatment allocation; (g) co-interventions were avoided or were similar for all groups; (h) compliance was acceptable in all groups.</s><s xml:id="_MKyCfWj">3. Attrition bias (two criteria), referring to systematic differences between the groups in participants who drop out and those who remain: (i) proper description of and acceptability of drop-out rate; (k) analysis according to intention-to-treat principle.</s><s xml:id="_h8v2Pb9">4. Detection bias (two criteria), referring to bias in how outcomes are ascertained, diagnosed or verified: (f) outcome assessor kept blind to participants' exposure to intervention; (j) timing of outcome assessment was similar in all groups.</s></p><p xml:id="_PmPjmdN"><s xml:id="_24cXZFW">Each criterion was scored with a 'yes', 'unclear' or 'no', where 'yes' indicates the criteria have been met and thus suggest a low risk of bias.</s><s xml:id="_WXMJjSD">The methodological quality of a study was considered high when six or more criteria were met.</s><s xml:id="_cBmgxEm">Disagreements between the reviewers were resolved by discussion.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_s3KBBeg">Categorization of interventions and study outcomes</head><p xml:id="_MrYNN8q"><s xml:id="_Z4daGDY">We categorized the type of electronic reminder in three categories: SMS reminder; audio/visual reminder from ERD; and reminder via pager systems.</s><s xml:id="_ruj9FUf">The effect of the intervention was also categorized in three categories: overall effect; subgroup effect; and no effect on adherence.</s><s xml:id="_jHw7AT2">Any effect, either overall or in subgroups, needed to be statistically significant (p&lt;0.05).</s><s xml:id="_vDHtJdM">Furthermore, we investigated both short-term (follow-up period &lt;6 months) and long-term (follow-up period $6 months) effects.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_VHjXuUm">RESULTS</head><p xml:id="_VaVnJKu"><s xml:id="_NTRKyYu">A total of 813 hits, 527 of which were unique, resulted from the electronic database searches.</s><s xml:id="_mMAGYKh">Searching references from reviews provided six potentially relevant studies.</s><s xml:id="_SPwNkF9">After screening the title and abstract, 491 references were excluded because they did not</s></p><p xml:id="_PVxxZvv"><s xml:id="_MhjJmfU">Table 1 Continued Author, study design Study population Type of reminder Description of intervention Type of adherence measure Timing of adherence measurement Main findings Simoni et al, 39 RCT parallel Adult patients with HIV (n¼224) Two-way pager system Three interventions: (1) peer support: six peer meetings and weekly phone calls from peers to participants.</s><s xml:id="_QwAxdY4">(2) use of two-way pager system: study coordinator customized message schedule to patients' daily regimen.</s><s xml:id="_MYNkzph">In addition to dose reminders, three other messages were sent: educational; entertainment; adherence assessments.</s><s xml:id="_mzpEedc">Minimum of three pager messages sent daily for 2 months.</s><s xml:id="_EMh444h">Pages gradually tapered in third month.</s><s xml:id="_p8MKedA">Confirmation page was requested.</s><s xml:id="_yVcr2kT">(3) peer support and pager combined.</s><s xml:id="_RgvxNRF">Self-report and electronic monitoring At months 3, 6 and 9 Pager support did not have a significant effect on adherence at 3, 6, or 9 months either measured with self-report or electronic monitoring.</s><s xml:id="_PP6JCkd">Safren et al, 40 RCT parallel Adult patients with HIV (n¼70) One-way pager system Study staff used website to input patients' schedule of daily pages, which is linked to paging service delivering messages (eg, 'Take 2 Combivir with water' every day at 09:00, 'Take the 2 blue pills now') to patients' pagers at designated times.</s><s xml:id="_5jMSthT">Study staff could incorporate other reminders (eg, timing of meals, appointments).</s><s xml:id="_9GkPH9v">No response required.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_PU6vKMR">Electronic monitoring</head><p xml:id="_zJrv4yT"><s xml:id="_W5PPagk">Baseline and weeks 2 and 12 Patients using the pager system revealed greater improvements in adherence at weeks 2 and 12 than patients who are only monitored.</s><s xml:id="_YTmQEvA">But at both assessment points, adherence was less than optimal (&lt;70%).</s></p><p xml:id="_9dNHac7"><s xml:id="_VSB4fzX">CAS, composite adherence score; DMAS, disease management assistance system; HAART, highly active antiretroviral therapy; HHDC, helping hand data capture; IDAS II, intelligent drug administration system; RCT, randomized controlled trial; SMS, short message service; TDA, travatan dosing aid.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ME3YZvH">Box 1 Principles of BES Evidence</head><p xml:id="_weG4p3D"><s xml:id="_3k9BHGn">Provided by consistent significant findings in outcome measures in at least two high quality RCT.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_c58e4sr">Moderate evidence</head><p xml:id="_FtDFfY3"><s xml:id="_UAApCwr">Provided by consistent significant findings in outcome measures in at least one high quality RCT and at least one low quality RCT or high quality CCT.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_kP4tHnk">Limited evidence</head><p xml:id="_d8QS63N"><s xml:id="_MXwpAsr">Provided by significant findings in outcome measures in at least one high quality RCT or provided by consistent significant findings in outcome measures in at least two high quality CCT (in the absence of high quality RCT).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ejK3pzD">Indicative findings</head><p xml:id="_d38Gw9c"><s xml:id="_r8RjAe4">Provided by significant findings in outcome measures in at least one high quality CCT or low quality RCT (in the absence of high quality RCT).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_XtXHUkD">No/insufficient evidence</head><p xml:id="_dYJdhdj"><s xml:id="_6PYbZf7">If the number of studies that show evidence is less than 50% of the total number of studies found within the same category of methodological quality and study design or if the results of eligible studies do not meet the criteria for one of the above stated levels of evidence or in case of conflicting (significantly positive and significantly negative) results among RCT and CCT or in the case of no eligible studies.</s></p><p xml:id="_V4urrgV"><s xml:id="_xkvF8HJ">meet the inclusion criteria.</s><s xml:id="_X9cMpG6">Of the remaining 42 references, full text was obtained and assessed for inclusion in the review.</s><s xml:id="_hDGWy3G">Details on excluded studies in this stage are given in supplementary appendix A (available online only).</s><s xml:id="_mwt9UbY">Finally, a total of 13 studies met all inclusion criteria (see figure <ref type="figure">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_fsNsavg">Description of the studies</head><p xml:id="_KUwu9WW"><s xml:id="_Tf6FCb6">Table <ref type="table" target="#tab_1">1</ref> shows the main characteristics of the 13 included studies (for a more detailed description, see supplementary appendix B, available online only).</s><s xml:id="_6DCAEpN">The study population varied: patients on antiretroviral therapy (five studies), <ref type="bibr">28 29 36 39 40</ref> patients with hypertension (three studies), <ref type="bibr">32 35 37</ref> patients with asthma (two studies), <ref type="bibr">31 34</ref> patients with glaucoma (two studies) <ref type="bibr">33 38</ref> and women using oral contraceptives (one study). <ref type="bibr" target="#b29">30</ref></s><s xml:id="_ca8feDE">All studies involved adult patients, except for one study that also included adolescents aged 13 years or older. <ref type="bibr" target="#b33">34</ref></s><s xml:id="_cdPEjcQ">The duration of medication use varied across the studies and also within the studies.</s></p><p xml:id="_PDx3EQC"><s xml:id="_BFF2Mnh">Seven studies included patients initiating or changing treatment, <ref type="bibr">29 30</ref> 32e34 36 39 four studies included patients currently using medication, <ref type="bibr">28 37 38 40</ref> and two studies included both new and current users. <ref type="bibr">31 35</ref></s><s xml:id="_8JN9cTr">Four interventions tested the effect of SMS reminders on patients' adherence, 28e31 seven studies evaluated an ERD with audiovisual medication reminders, 32e38 and two studies concentrated on the effect of a pager reminder. <ref type="bibr">39 40</ref></s><s xml:id="_xnHn4eW">Almost half of the studies used multiple measures to assess adherence.</s><s xml:id="_XFj44xn">Electronic monitoring (electronically registering the date and time of every medication intake) was used in 11 studies.</s><s xml:id="_25wH9uB">Six studies exclusively used electronic monitoring, <ref type="bibr">29 31 33e35 40</ref> four combined electronic monitoring with self-report <ref type="bibr">30 32 36 39</ref> and one combined electronic monitoring with both pill count and self-report. <ref type="bibr" target="#b27">28</ref></s><s xml:id="_Ja2tEVk">One study exclusively used pill count, <ref type="bibr" target="#b36">37</ref> one study assessed bottle weight (medication in soluble form) with self-report. <ref type="bibr" target="#b37">38</ref></s><s xml:id="_GNZAv8G">Only three studies followed patients for a period of 6 months or longer. <ref type="bibr">29 32 39</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_GCPPryB">Methodological quality</head><p xml:id="_BFE6tKF"><s xml:id="_jw5dx8R">The methodological quality (risk of bias) of the 13 included RCT was assessed.</s><s xml:id="_DYRPz4k">Seven studies were classified as high quality studies, six studies had a low quality (table <ref type="table" target="#tab_3">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mnRVyuQ">Effectiveness of interventions</head><p xml:id="_cGABjQe"><s xml:id="_9MJfFfa">Tables <ref type="table" target="#tab_4">3</ref> and <ref type="table" target="#tab_5">4</ref> summarize the effects on adherence, methodological quality of the studies, and characteristics of the intervention (studied medication, type of electronic reminder, and type of adherence measurement), by length of follow-up period.</s><s xml:id="_qUqnaUC">Eight (four high and four low quality) studies reported significant overall effects on patients' adherence as a result of an electronic reminder.</s><s xml:id="_exzCv4g">Hardy et al 28 compared the adherence of HIV patients receiving SMS reminders with patients using a beeper as a reminder and found a significant difference in favor of SMS reminding.</s><s xml:id="_DxpH9fW">Strandbygaard et al 31 revealed that adherence rates of asthma patients who received daily SMS reminders were higher than those of patients who were not reminded.</s><s xml:id="_U9HdBnN">The third study also focused on asthma patients and found that an ERD with an audiovisual reminder significantly improved adherence. <ref type="bibr" target="#b33">34</ref></s><s xml:id="_JN5H6kH">Two other studies also used an ERD with audiovisual reminders, both in patients with glaucoma, and found higher adherence rates in patients receiving these reminders. <ref type="bibr">33 38</ref></s><s xml:id="_bwU44gw">Da Costa et al 37 reported significant differences in adherence between patients with hypertension who used a reminder alarm card that produced a beep at predetermined times, and patients who did not.</s><s xml:id="_wdaPgat">Safren et al <ref type="bibr" target="#b39">40</ref> revealed improvements in adherence in patients with HIV as a result of reminder messages sent to patients' pagers.</s><s xml:id="_T6KKanu">The last study found that patients who were reminded once a week had higher adherence rates than patients reminded daily or patients not reminded at all. <ref type="bibr" target="#b28">29</ref></s><s xml:id="_cy92u7u">One (high quality) study revealed significant effects in a subgroup of the intervention group; Andrade et al <ref type="bibr" target="#b35">36</ref> found that an ERD with audiovisual reminders significantly improved adherence in memory-impaired patients (assessed with neuropsychological tests), but not in memory-intact patients.</s><s xml:id="_eBAAd4z">Finally, four (two high and two low quality) studies, two of which measured the impact of the reminder on multiple time points, showed no effects on adherence at any time point. <ref type="bibr">30 32 35 39</ref></s><s xml:id="_Fn46sBy">lation between type of reminder and effects</s></p><p xml:id="_VwWXZQW"><s xml:id="_atTcwgu">Four studies used SMS reminders, three of which showed significant positive effects on adherence.</s><s xml:id="_sBXNZR8">Those studies used either personalized text messages that requested a reply from patients when taking the medication, <ref type="bibr" target="#b27">28</ref> or standardized text messages without requiring acknowledgment. <ref type="bibr">29 31</ref></s><s xml:id="_h8WSnG2">The study revealing no effect used standardized messages without requesting a reply. <ref type="bibr" target="#b29">30</ref></s><s xml:id="_2H5e3ds">igure <ref type="figure">1</ref> Flowchart of study inclusion.</s><s xml:id="_hfm4YyR">Four of the seven studies evaluating audio/visual reminders from ERD significantly improved patients' adherence.</s><s xml:id="_K3FHftv">Three of them used an ERD that produced both an audible and visual reminder, <ref type="bibr">33 34 38</ref> the fourth used an ERD that only emitted an audible reminder. <ref type="bibr" target="#b36">37</ref></s><s xml:id="_bMqmVFU">The one study that found a subgroup effect evaluated an ERD with an audible reminder. <ref type="bibr" target="#b35">36</ref></s><s xml:id="_E5V6NBM">Two studies showed no effects, both of them used an ERD that accommodated blister packs. <ref type="bibr">32 35</ref></s><s xml:id="_5Xa3Uxt">wo interventions used pagers, one of which revealed a significant effect. <ref type="bibr" target="#b39">40</ref></s><s xml:id="_TzQUfpN">This study delivered standardized text messages to patients' pagers at predetermined times and requested no reply. <ref type="bibr" target="#b39">40</ref></s><s xml:id="_mTWSNqN">The pager intervention revealing no effects delivered a minimum of three pager messages daily and a confirmation return page was requested for every message. <ref type="bibr" target="#b38">39</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_C6m4yzh">Relation between length of the follow-up period and effects</head><p xml:id="_pFkHtAt"><s xml:id="_X2sh79u">Ten studies had a follow-up period shorter than 6 months.</s><s xml:id="_RfBeTSS">Within this group, all but two studies revealed significant overall effects <ref type="bibr">28 31 33 34 36e38 40</ref> or a subgroup effect. <ref type="bibr" target="#b35">36</ref></s><s xml:id="_GVSM4KF">The follow-up period varied from 3 weeks to 3 months.</s><s xml:id="_kMV7PQb">In contrast, only one of three studies following patients for over 6 months reported significant effects.</s><s xml:id="_yevsG3n">That study followed patients for 48 weeks. <ref type="bibr" target="#b28">29</ref></s><s xml:id="_QPU7VR7">he two studies reporting no effects followed patients for 9 <ref type="bibr" target="#b38">39</ref> and 12 months. <ref type="bibr" target="#b31">32</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_XBgDc7z">Relation between type of adherence measurement and effects</head><p xml:id="_uK8X7Dh"><s xml:id="_HVks4va">Eleven studies used electronic monitoring as a method to measure adherence.</s><s xml:id="_BExEbfg">Six of them reported significant overall effects, <ref type="bibr">28 29 31 33 34 40</ref> one found a subgroup effect. <ref type="bibr" target="#b35">36</ref></s><s xml:id="_5qCaJrk">In addition to electronic monitoring, five studies used self-report to measure adherence.</s><s xml:id="_cCZUYqe">Two of those studies showed inconclusive results between the two methods: significant effects were only found when adherence was measured with electronic monitoring, not with self-report. <ref type="bibr">28 36</ref></s><s xml:id="_bpu6pca">One study also used pill count as a third method for measuring adherence, but again effects were only found with electronic monitoring. <ref type="bibr" target="#b27">28</ref></s><s xml:id="_fq9WnkE">One study exclusively using pill count <ref type="bibr" target="#b36">37</ref> as well as a study using 'pill count' (or weight of medication solution) combined with self-report <ref type="bibr" target="#b37">38</ref> showed significant effects on adherence.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_YHSesV8">Other characteristics</head><p xml:id="_zB95Qpx"><s xml:id="_KeaBTGN">The number of patients participating in the studies was often limited: six studies included fewer than 30 patients in each arm.</s><s xml:id="_qeBYkeY">Despite this limited sample size, four of them revealed significant effects <ref type="bibr">28 31 33 38</ref> and one a subgroup effect <ref type="bibr" target="#b35">36</ref> on adherence.</s><s xml:id="_9Hna9YK">In addition, four studies included between 30 and 50 patients in each arm, three of which showed significant effects. <ref type="bibr">34 37 40</ref></s><s xml:id="_7SCRtJz">Of the three studies that included more than 50 patients in each arm, one study reported significant effects. <ref type="bibr" target="#b28">29</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_SWQ3Qnt">BES and sensitivity analysis</head><p xml:id="_mbYFvsq"><s xml:id="_AJQr2mF">Seven of the 13 included RCT were classified as high quality studies.</s><s xml:id="_uJttBuA">Four of them reported significant overall effects, three of which were effects measured short term (&lt;6 months follow-up).</s><s xml:id="_dgF6Qet">In addition, four low quality studies found significant effects, all short term.</s><s xml:id="_4mF26s5">Only one high quality study found significant effects measured long term (6 months or longer follow-up).</s></p><p xml:id="_nBAzmx2"><s xml:id="_vmWWNEQ">Using the principles of BES (see box 1), these results indicate that there is evidence of the short-term effectiveness of electronic reminders in improving patients' adherence to medication.</s><s xml:id="_R466aEZ">Regarding the type of electronic reminder, there is evidence resulting from three high quality studies of the effectiveness of SMS reminders in improving adherence. <ref type="bibr">28 31</ref></s><s xml:id="_stAyxZp">Moderate evidence was found for audiovisual reminders from ERD as a strategy to improve adherence, as one high quality and three low quality studies found significant effects. <ref type="bibr">33 34 37 38</ref></s><s xml:id="_C9ehGv6">There is insufficient evidence for the effect of pager reminders in particular, as the low quality study reported significant effects. <ref type="bibr" target="#b39">40</ref></s><s xml:id="_wrXJTDZ">s sensitivity analysis, BES was first repeated using seven high quality RCT (thus disregarding six low quality RCT).</s><s xml:id="_dmq368Y">Evidence  for the short-term effectiveness as well as evidence for the effectiveness of SMS reminders in particular remained.</s><s xml:id="_W7Eyy5a">However, limited evidence is now found for the effectiveness of ERD with audiovisual reminders.</s><s xml:id="_VDDVw7m">Second, BES was repeated using four instead of six (out of 11) validity criteria for classifying RCT as high quality studies.</s><s xml:id="_7ZqSVus">Again, evidence for the short-term effectiveness as well as evidence for SMS reminders remained.</s><s xml:id="_ttmg2H4">In addition, evidence was also provided for audiovisual reminders from ERD.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_DbJFJxf">DISCUSSION</head><p xml:id="_jCvF79v"><s xml:id="_FGknU5N">This review provides evidence for the short-term effectiveness of electronic reminders in improving adherence in patients using chronic medication.</s><s xml:id="_fxgusmA">Significant improvements in adherence were found in all but two studies following patients for a period of less than 6 months (four high and four low quality studies).</s></p><p xml:id="_uwhDZev"><s xml:id="_ccvRQJY">Only one (with a high quality) of three studies with long-term follow-up reported significant effects on patients' adherence.</s></p><p xml:id="_5RAaSm2"><s xml:id="_ybyruzb">The electronic reminders evaluated in those studies included SMS reminders, audio/visual reminders from ERD and reminders delivered to pagers.</s><s xml:id="_kJnYUZ3">Stratified by the type of electronic reminder, our review shows that SMS reminders in particular but also ERD can be effective strategies for improving patients' adherence in the short run.</s></p><p xml:id="_Pq9hmQY"><s xml:id="_6pspk8v">Most studies included in this review followed patients for a period of less than 6 months.</s><s xml:id="_ZVszkxa">It is, however, important to investigate whether the effects of electronic reminding remain for a longer time period.</s><s xml:id="_fhsENaa">Patients who are adherent at first can become non-adherent over time. <ref type="bibr" target="#b42">43</ref></s><s xml:id="_NwjuZzK">Furthermore, all 13 studies included in this review automatically sent electronic reminders regardless of whether or not patients took their medication.</s><s xml:id="_aAQ9gmy">This may negatively influence the long-term effects of electronic reminders, as these automated reminders can become a routine resulting in habituation.</s><s xml:id="_Umwq452">This may be the reason that Pop-Eleches et al <ref type="bibr" target="#b28">29</ref> found that SMS reminders sent once a week significantly improved the adherence of HIV patients whereas daily reminders did not.</s><s xml:id="_HQqxYU6">Further research is needed to investigate the influence of the frequency with which reminders are sent in improving of adherence.</s><s xml:id="_F9E3f2u">Moreover, real time adherence monitoring is now upcoming, <ref type="bibr">44 45</ref> offering the possibility to intervene only when patients miss a dose, thus avoiding the reminders becoming routine.</s><s xml:id="_fQYxtuG">The effectiveness of this nonautomated type of electronic reminding on adherence is currently being investigated. <ref type="bibr" target="#b45">46</ref></s><s xml:id="_cBzmQJ6">ith technology evolving rapidly, the use of older technologies such as pager systems is likely to decrease and new technologies may arise, such as applications for smart phones.</s><s xml:id="_Zp2WgZY">Currently, SMS reminding is increasingly being implemented in interventions aimed at improving adherence as mobile penetration is high.</s><s xml:id="_uvcuc5K">The effectiveness is influenced by patients' willingness to receive SMS reminders.</s><s xml:id="_HQgdrJF">Two of the included studies reported patient experiences with SMS reminding. <ref type="bibr">30 31</ref></s><s xml:id="_69MgRAY">Both studies reported a positive evaluation of this type of electronic reminding, although in one of the studies the majority of patients indicated that the predetermined time at which the reminder was sent daily was unsuitable. <ref type="bibr" target="#b30">31</ref></s><s xml:id="_U2cP5F4">In addition, three included studies evaluating ERD reported that these devices were well accepted by patients, <ref type="bibr">35 36 38</ref> which is in line with other research. <ref type="bibr">47 48</ref></s><s xml:id="_73vKmj3">ur review showed that SMS reminders are effective in increasing adherence.</s><s xml:id="_epEPYvy">There are, however, differences in the SMS reminders sent.</s><s xml:id="_sqgq6fj">One study used personalized text messages that requested a reply, <ref type="bibr" target="#b27">28</ref> the other two studies yielding significant effects sent standardized text messages without requiring acknowledgment. <ref type="bibr">29 31</ref></s><s xml:id="_DPnCtDq">Earlier research showed that a tailored message is usually more effective than a standard text. <ref type="bibr" target="#b48">49</ref></s><s xml:id="_qCSUxVH">This cannot be confirmed by our findings.</s><s xml:id="_wP54qPG">However, more studies are needed to investigate the influence of the content of reminder messages on adherence behavior.</s></p><p xml:id="_zrHmdcW"><s xml:id="_EFZQDHw">Reminders can especially be used to modify the behavior of unintentionally non-adherent patients, ie, patients who are willing to take their medication but forget it or are inaccurate. <ref type="bibr" target="#b7">8</ref></s><s xml:id="_BYsxBBS">onetheless, none of the included studies focused specifically on this patient group, implying that the intervention was possibly not suited for some of the patients; those who deliberately miss or alter their doses and make a rational decision to do so by weighing pros and cons of the medication.</s><s xml:id="_3tprHP2">Interventions using reminders may be more effective when they are solely focused on patients who are unintentionally non-adherent.</s><s xml:id="_7E4R58f">On the other hand, using text messages, for example, to stimulate patients who doubt the effectiveness of medication by stressing the importance of the intake in the message may provide a solution for intentionally non-adherent patients. <ref type="bibr" target="#b49">50</ref></s><s xml:id="_nTn6eqp">eminders can be beneficial for improving adherence in patients of all ages.</s><s xml:id="_DxwUQWH">Elderly patients may be at risk of forgetting to take their medication because of memory problems.</s><s xml:id="_qFhbEdu">Adolescents, on the other hand, may be at risk for forgetting their dose because of their busy (social) lives.</s><s xml:id="_3c75VZB">Zelikovsky et al <ref type="bibr" target="#b17">18</ref> reported that being out with friends and participating in activities were reasons for forgetting among adolescent renal transplant candidates.</s><s xml:id="_4sqBnjZ">Furthermore, as adolescents extensively use mobile phones, SMS reminders might be particularly useful for reminding them.</s><s xml:id="_UZsZRnc">Miloh et al, <ref type="bibr" target="#b50">51</ref> for example, showed improved adherence rates as a result of text messaging in pediatric liver transplant recipients.</s><s xml:id="_S2TBxFA">None of the studies included in our review, though, specifically targeted the pediatric population.</s><s xml:id="_d2JyJAt">Future studies involving the pediatric population are recommended.</s></p><p xml:id="_ZwyBx2M"><s xml:id="_7fW93H8">Electronic monitoring is currently seen as the most reliable and objective method in measuring adherence, while self-report is considered less reliable as this measure tends to overestimate adherence. <ref type="bibr">52 53</ref></s><s xml:id="_XJYRQkA">Most studies included in the review used electronic monitoring for adherence measurement, sometimes combined with self-report.</s><s xml:id="_xwZfSBK">In two studies, in which adherence was measured with both electronic monitoring and self-report, effects were only found when adherence was measured with electronic monitoring, while no effects were found for selfreport.</s><s xml:id="_J6nVEW9">A possible explanation may be that with self-report patients report a high adherence rate from the beginning, leaving no or insufficient room for improvement.</s><s xml:id="_HrCPAwR">These findings emphasize the importance of incorporating objective methods for adherence measurement into studies whenever possible. <ref type="bibr" target="#b5">6</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6ErV6r2">Limitations</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_3xmegNV">Limitations of the included studies</head><p xml:id="_XqPStbp"><s xml:id="_M34C2zH">The methodological quality of the studies varied.</s><s xml:id="_yTQsdjx">In studies identified as low quality, mostly the risk of selection and attrition bias is present.</s><s xml:id="_vNh7YGz">By using a BES, this methodological quality was taken into account in attributing levels of evidence to effects found in studies.</s></p><p xml:id="_BG2XmVX"><s xml:id="_rCytpMu">The electronic database searches provided five studies in which a more complex intervention was used, with an electronic reminder as one of the aspects of the intervention.</s><s xml:id="_Bz53mgq"><ref type="bibr">54e58</ref> Those studies only reported the total effect of the complex intervention on patients' medication adherence, no direct relation between the reminder and adherence was reported.</s><s xml:id="_76RSKuZ">Therefore, those studies could not contribute to this review, thus we decided to exclude those studies.</s></p><p xml:id="_NjGWPv4"><s xml:id="_ScTrcBz">The primary aim of electronic reminders is to improve patients' medication adherence.</s><s xml:id="_cdUAkST">Therefore, we focused not on clinical outcomes, but on adherence as (one of the) main outcome measures.</s><s xml:id="_ETRrw3n">In adherence research, a patient is often classified as adherent when an adherence rate of over 80% is reached. <ref type="bibr" target="#b58">59</ref></s><s xml:id="_gkP5Urn">This cut-off point indicates the minimum level of adherence needed for therapeutic effect.</s><s xml:id="_GvAnG79">In the HIV population, the cut-off point is 90%.</s><s xml:id="_nEyUF4W">Although often used, these cut-off points are arbitrary.</s><s xml:id="_apAgKUx">Only two studies in our review used a cutoff point for adherence.</s><s xml:id="_36JPnx4">Pop-Eleches et al 29 used a binary indicator of whether HIV patients achieved more than 90% adherence as a primary outcome.</s><s xml:id="_SSksFwg">Charles et al 34 used cut-off points of over 50%, over 80% and over 90% adherence for asthma patients.</s><s xml:id="_pGUvSN6">Both studies, however, did not link their findings to clinical outcomes nor reported on the clinical significance of the effects found.</s><s xml:id="_UqTF9Fp">Trials aiming to evaluate the effects on patients' medication adherence usually have insufficient power to detect significant differences in clinical outcome measures.</s><s xml:id="_f7Nd3qe">Of the nine studies that showed an effect on adherence, three studies also reported clinical outcomes, <ref type="bibr">31 36 37</ref> of which one found a significant improvement in the intervention group. <ref type="bibr" target="#b35">36</ref></s><s xml:id="_rVjSgVF">Although adherence appears to be an intermediate outcome, there is evidence of the association between increased adherence rates and positive health outcomes. <ref type="bibr">4 60</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KMhHdTv">Limitations of the review</head><p xml:id="_We2kb7Q"><s xml:id="_bDr5kW8">A methodological limitation of our review may be that we used a 'top-down' approach in our search strategy, which means that we relied on existing databases and their search terms for identifying relevant studies.</s><s xml:id="_tZrN35v">This may lead to missing relevant studies due to miscoding of search terms.</s><s xml:id="_knmFQJ3">A 'bottom-up' strategy, relying on searching existing databases in the broadest way possible, is significantly more time and labor-intensive but has the advantage of being comprehensible.</s><s xml:id="_sMTnSdE">To reduce this potential problem, we used the snowball method to identify studies that we possibly missed with our top-down strategy in addition to the electronic database searches.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_EVWDD62">Clinical implications</head><p xml:id="_kQxyvau"><s xml:id="_GDPm5Hn">After providing patients with the electronic reminders, no additional effort is needed from healthcare providers, making this an intervention easy to implement in daily practice.</s><s xml:id="_JXtkbGB">Furthermore, electronic reminders and especially SMS reminders appear to be easily integrated into patients' lives.</s><s xml:id="_TUhMcQ7">As such, this seems to be a simple intervention for both patient and professional for enhancing medication adherence.</s><s xml:id="_pdy5DWn">However, the healthcare system needs to be ready to include the use of electronic reminders in usual care for patients using chronic medication.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_JbJfYyP">Implications for further research</head><p xml:id="_V8xHa4F"><s xml:id="_qwaKDnq">Future studies should aim specifically at patients who are unintentionally non-adherent in examining the effects of electronic reminders on adherence.</s><s xml:id="_qADFfsv">In addition, further research is needed to identify for which patient groups electronic reminding is most beneficial, for example, studies involving the pediatric population and studies involving patients with other types of chronic illnesses.</s><s xml:id="_vbGHKqS">Moreover, the included studies mostly found short-term improvements.</s><s xml:id="_tRPKjY2">Future studies should investigate the long-term effects of electronic reminders and search for additional features of electronic reminding to improve adherence in the long-term.</s><s xml:id="_N3SutgE">One example may be not to send patients reminders daily at predetermined times, but to intervene only when necessary, by sending patients reminders only when they forget to take their medication. <ref type="bibr" target="#b45">46</ref></s><s xml:id="_U2SDj99">Another example may be to tailor the content of the reminder message to the needs of the patients based on their illness and treatment beliefs. <ref type="bibr" target="#b49">50</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_XywDtEe">CONCLUSIONS</head><p xml:id="_xTGhKfB"><s xml:id="_XerTxkV">This review shows that electronic reminders lead to short-term improvements of patients' adherence to chronic medication, while the long-term effects remain unclear.</s><s xml:id="_r7jyNxB">The increasing opportunities of new technologies make it possible to tailor reminding both in timing (only when needed) and in content (tailored messages).</s><s xml:id="_tkZPMuU">In this way, long-term improvements in medication adherence may be achieved.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="5,67.07,481.55,196.77,255.12" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1</head><label>1</label><figDesc><div><p><s xml:id="_VGqSy32">42in characteristics of included studies (ranked according to type of reminder and year of publication)It was not possible to perform a meta-analysis because of the heterogeneity of methods and interventions used.Therefore, a best evidence synthesis (BES) was conducted, based on the one proposed by van Tulder et al41and adapted by Steultjens et al.42This synthesis takes the design, methodological quality and outcomes of the studies into account and attributes various levels of evidence to the effectiveness of interventions.</s><s xml:id="_jUb7Njd">Box 1 presents the principles of BES.</s><s xml:id="_znp72ZA">Sensitivity analysis was performed to identify how sensitive the results of BES are to changes in the way this synthesis was performed.</s><s xml:id="_tf6rWjY">For the sensitivity analysis, BES was repeated in two ways: low quality studies were excluded; studies were classified as high quality if they met four instead of six internal validity criteria.</s></p></div></figDesc><table><row><cell></cell><cell>Main findings</cell><cell>Significant difference in adherence at weeks 3 and 6</cell><cell>were found in favor of the SMS, when measured with</cell><cell>electronic monitoring and CAS. No differences were</cell><cell>found with self-report nor pill count.</cell><cell></cell><cell>Weekly reminders significantly increased percentage of</cell><cell>participants achieving 90% adherence by 13e16%. No</cell><cell>differences were found between long and short</cell><cell>reminders. Daily reminders did not improve adherence.</cell><cell></cell><cell>No difference in mean number of missed pills per cycle</cell><cell>with either self-report or electronic monitoring between</cell><cell>women who received SMS reminders and women who</cell><cell>did not.</cell><cell>Patients who received a daily SMS reminder</cell><cell>remembered to take, on average, significantly more</cell><cell>doses (about 18%).</cell><cell>Use of the HHDC device with audiovisual reminders did</cell><cell>not lead to significant improvement in adherence.</cell><cell></cell><cell>Significant differences in mean adherence and rate of</cell><cell>missed doses between patients using TDA with</cell><cell>audiovisual reminders and patients using TDA without</cell><cell>reminders.</cell><cell>Use of SmartInhaler with audiovisual reminders</cell><cell>significantly improved adherence from 74% to 93%.</cell><cell>Approx. 1 in 4 patients using the device with reminders</cell><cell>had &lt;50% adherence, compared with 1 in 20 patients</cell><cell>using the device without reminders.</cell><cell>Median taking adherence was high and did not differ</cell><cell>between patients using IDAS II and patients using MEMS</cell><cell>caps. Regularity of drug intake timing was significantly</cell><cell>higher with IDAS II compared with MEMS.</cell><cell>No differences in adherence between patients who used</cell><cell>DMAS and patients who did not. Stratified to memory</cell><cell>impairment: adherence was significantly higher in</cell><cell>memory-impaired patients using DMAS than memory-</cell><cell>intact patients using DMAS.</cell><cell>Adherence of patients using the reminder alarm card</cell><cell>was higher at all time points than that of patients not</cell><cell>using this card, reaching statistical significance at the</cell><cell>third month (mean adherence difference 10%).</cell><cell>Patient using TimeCap with audiovisual reminders</cell><cell>administered significantly more eye drops (about one</cell><cell>additional dose of pilocarpine per day) than patients who</cell><cell>did not use TimeCap.</cell></row><row><cell>Timing of adherence</cell><cell>measurement</cell><cell>Baseline, week 3</cell><cell>and week 6</cell><cell></cell><cell></cell><cell></cell><cell>Every 12-week</cell><cell>period in 48 weeks</cell><cell></cell><cell></cell><cell></cell><cell>Every month</cell><cell>for 3 months</cell><cell></cell><cell></cell><cell>Week 4 and</cell><cell>week 12</cell><cell></cell><cell>At month 6 and</cell><cell>month 12 (after</cell><cell>crossover)</cell><cell>At 3e5 weeks</cell><cell></cell><cell></cell><cell></cell><cell>Baseline and</cell><cell>week 6, 12,</cell><cell>18 and 24</cell><cell></cell><cell></cell><cell>Baseline and</cell><cell>months 2 and</cell><cell>4 (after crossover)</cell><cell></cell><cell>Weeks 4, 8, 12,</cell><cell>16, 20 and 24</cell><cell></cell><cell></cell><cell></cell><cell>Baseline and</cell><cell>months 1, 2 and 3</cell><cell></cell><cell></cell><cell>At days 30 and 60</cell></row><row><cell>Type of adherence</cell><cell>measure</cell><cell>Self-report, pill</cell><cell>count, electronic</cell><cell>monitoring, CAS</cell><cell></cell><cell></cell><cell>Electronic</cell><cell>monitoring</cell><cell></cell><cell></cell><cell></cell><cell>Self-report and</cell><cell>electronic</cell><cell>monitoring</cell><cell></cell><cell>Electronic</cell><cell>monitoring</cell><cell></cell><cell>Self-report and</cell><cell>electronic</cell><cell>monitoring</cell><cell>Electronic</cell><cell>monitoring</cell><cell></cell><cell></cell><cell>Electronic</cell><cell>monitoring</cell><cell></cell><cell></cell><cell></cell><cell>Electronic</cell><cell>monitoring</cell><cell></cell><cell></cell><cell>Self-report and</cell><cell>electronic</cell><cell>monitoring</cell><cell></cell><cell></cell><cell>Pill count</cell><cell></cell><cell></cell><cell></cell><cell>Self-report and</cell><cell>amount of solution</cell><cell>used estimated by</cell><cell>weighing</cell><cell>of bottle</cell></row><row><cell></cell><cell>Description of intervention</cell><cell>Daily personalized (by adding info on topic chosen by</cell><cell>patient, eg, news, weather, sports) text messages sent</cell><cell>for each dose scheduled by care giver. Response with</cell><cell>text message required. If no response given, the phone</cell><cell>would beep every 15 min.</cell><cell>Four interventions: (1) daily short reminder; (2) daily</cell><cell>long reminder; (3) weekly short reminder; (4) weekly long</cell><cell>reminder. Short message: 'This is your reminder', long</cell><cell>message providing additional support: 'This is your</cell><cell>reminder. Be strong and courageous, we care about you'.</cell><cell>Message was sent at 12:00. No response required.</cell><cell></cell><cell>No response required.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Use of HHDC device operated with tablet blister packs,</cell><cell>which gives an audiovisual reminder when it is time to</cell><cell>take the medication.</cell><cell>Use of TDA, which has a LCD screen that displays a</cell><cell>flashing eye drop symbol on the front as and emits a</cell><cell>beep when patients are supposed to give themselves</cell><cell>a dose of medication.</cell><cell>Use of SmartInhaler, which emitted a beep at</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Use of DMAS device programmed with reminder</cell><cell>messages and dosing times for each medication in</cell><cell>the HAART regimen.</cell><cell></cell><cell></cell><cell>Use of alarm card set up to beep every day at fixed time,</cell><cell>preselected by pharmacist and/or patient. If alarm was</cell><cell>ignored, it would beep every 20 s for 3 h, then stop and</cell><cell>re-initiate 8 h later, beeping every 20 s for 1 h.</cell><cell>Use of TimeCap, a medication alarm device serving as cap</cell><cell>on medication bottle. It has a digital display that shows</cell><cell>time and day of week when the phial was last opened</cell><cell>and an alarm that beeps when a dose is due. If the beep</cell><cell>is ignored, the digital face flashes to provide a visual</cell><cell>reminder that a dose has been missed.</cell></row><row><cell></cell><cell>Type of reminder</cell><cell>SMS (vs beeper)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>SMS</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Electronic reminder</cell><cell>device with</cell><cell>audiovisual reminder</cell><cell>Electronic reminder</cell><cell>device with</cell><cell>audiovisual reminder</cell><cell></cell><cell>Electronic reminder</cell><cell>device with</cell><cell>audiovisual reminder</cell><cell></cell><cell></cell><cell>Electronic reminder</cell><cell>device with</cell><cell>audiovisual reminder</cell><cell>(versus MEMS caps)</cell><cell>Electronic reminder</cell><cell>device with audible</cell><cell>reminder</cell><cell></cell><cell></cell><cell>Electronic reminder</cell><cell>device with audible</cell><cell>reminder</cell><cell></cell><cell>Electronic reminder</cell><cell>device with</cell><cell>audiovisual reminder</cell></row><row><cell></cell><cell>Study population</cell><cell>Adult patients</cell><cell>with HIV (n¼19)</cell><cell></cell><cell></cell><cell></cell><cell>Adult patients</cell><cell>with HIV (n¼428)</cell><cell></cell><cell></cell><cell></cell><cell>Women on oral</cell><cell>contraceptives</cell><cell>(n¼73)</cell><cell></cell><cell>Adult patients</cell><cell>with asthma</cell><cell>(n¼26)</cell><cell>Adult patients</cell><cell>with hypertension</cell><cell>(n¼398)</cell><cell>Adult patients with</cell><cell>glaucoma (n¼42)</cell><cell></cell><cell></cell><cell>Adult and adolescent</cell><cell>patients with</cell><cell>asthma (n¼90)</cell><cell></cell><cell></cell><cell>Adult patients</cell><cell>with hypertension</cell><cell>(n¼24)</cell><cell></cell><cell>Adult patients</cell><cell>with HIV (n¼58)</cell><cell></cell><cell></cell><cell></cell><cell>Adult patients</cell><cell>with hypertension</cell><cell>(n¼71)</cell><cell></cell><cell>Adult patients</cell><cell>with glaucoma</cell><cell>(n¼13)</cell></row><row><cell>Author, study</cell><cell>design</cell><cell>Hardy et al, 28</cell><cell>RCT parallel</cell><cell></cell><cell></cell><cell></cell><cell>Pop-Eleches</cell><cell>et al, 29 RCT</cell><cell>parallel</cell><cell></cell><cell></cell><cell>Hou et al, 30</cell><cell>RCT parallel</cell><cell></cell><cell></cell><cell>Strandbygaard</cell><cell>et al, 31 RCT</cell><cell>parallel</cell><cell>Christensen</cell><cell>et al, 32 RCT</cell><cell>crossover</cell><cell>Ho et al, 33</cell><cell>RCT parallel</cell><cell></cell><cell></cell><cell>Charles et al, 34</cell><cell>RCT parallel</cell><cell></cell><cell></cell><cell></cell><cell>Santschi et al, 35</cell><cell>RCT crossover</cell><cell></cell><cell></cell><cell>Andrade et al, 36</cell><cell>RCT parallel</cell><cell></cell><cell></cell><cell></cell><cell>Da Costa et al, 37</cell><cell>RCT parallel</cell><cell></cell><cell></cell><cell>Laster et al, 38</cell><cell>RCT crossover</cell></row></table><note xml:id="_yAddsfg"><p>SMS</p><p>Daily text message 'Please remember to take your birth control pill' sent at a designated time chosen by patient.</p><p>SMS</p><p>Daily text message 'Remember to take your asthma medication morning and evening. From the Respiratory Unit' sent at 10:00. No response required.</p><p>predetermined times (selected by patient) once every 30 s for 60 min and stopped if device was actuated or after 60 min. Device had a light which was green before actuation, changing to red once the dose was taken.</p><p>Use of IDAS II that accommodates blister packs. Visual reminder (indicating time elapsed since last dose) and audible reminder, which sounds at chosen time for 1 min or until device is opened, and can be deactivated upon request.</p><p>Continued</p><p><s xml:id="_cV7mJdM">Data synthesis and sensitivity analysis</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2</head><label>2</label><figDesc><div><p xml:id="_W3r3QB9"><s xml:id="_yuduZcD">Methodological quality of included RCT</s></p></div></figDesc><table><row><cell>Study</cell><cell>Validity criteria met*</cell><cell>Methodological qualityy</cell></row><row><cell>Hardy et al 28</cell><cell>a, b, c, g, h, i, j</cell><cell>High</cell></row><row><cell>Pop-Eleches et al 29</cell><cell>a, c, g, h, i, j, k</cell><cell>High</cell></row><row><cell>Hou et al 30</cell><cell>a, b, c, f, g, h, i, j, k</cell><cell>High</cell></row><row><cell>Strandbygaard et al 31</cell><cell>a, c, g, h, i, j</cell><cell>High</cell></row><row><cell>Simoni et al 39</cell><cell>a, b, c, g, h, i, j, k</cell><cell>High</cell></row><row><cell>Charles et al 34</cell><cell>a, b, c, g, h, i, j</cell><cell>High</cell></row><row><cell>Andrade et al 36</cell><cell>c, g, h, i, j, k</cell><cell>High</cell></row><row><cell>Christensen et al 32</cell><cell>c, g, h, j</cell><cell>Low</cell></row><row><cell>Ho et al 33</cell><cell>g, h, j</cell><cell>Low</cell></row><row><cell>Santschi et al 35</cell><cell>a, g, h, i</cell><cell>Low</cell></row><row><cell>Da Costa et al 37</cell><cell>c, g, h, j</cell><cell>Low</cell></row><row><cell>Safren et al 40</cell><cell>c, g, h, j, k</cell><cell>Low</cell></row><row><cell>Laster et al 38</cell><cell>g, h, i, j</cell><cell>Low</cell></row><row><cell cols="3">*Selection bias: criteria a, b, c; performance bias: criteria d, e, g and h; attrition bias: criteria</cell></row><row><cell cols="2">i and k; detection bias: criteria f and j.</cell><cell></cell></row><row><cell cols="3">yHigh quality: six or more criteria met; low quality: five or fewer criteria met.</cell></row><row><cell cols="2">RCT, randomised controlled trial.</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 3</head><label>3</label><figDesc><div><p xml:id="_5rUeDSm"><s xml:id="_EHwSUWP">Characteristics and effectiveness of interventions with a short-term follow-up period (&lt;6 months) ++¼ Overall effect; + ¼ subgroup effect; e ¼ no effect.</s><s xml:id="_sxTFPps">yAmount of eye drops left estimated by bottle weight.</s><s xml:id="_h45aFm7">ERD, electronic reminder device; SMS, short message service.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Short-term effect* on adherence measured with:</cell><cell></cell></row><row><cell>Study</cell><cell>Medication for</cell><cell>Type of reminder</cell><cell>Study quality</cell><cell>Electronic monitoring</cell><cell>Self-report</cell><cell>Pill count</cell></row><row><cell>Hou et al 30</cell><cell>Contraception</cell><cell>SMS</cell><cell>High</cell><cell>e</cell><cell>e</cell><cell></cell></row><row><cell>Hardy et al 28</cell><cell>HIV</cell><cell>SMS</cell><cell>High</cell><cell>++</cell><cell>e</cell><cell>e</cell></row><row><cell>Strandbygaard et al 31</cell><cell>Asthma</cell><cell>SMS</cell><cell>High</cell><cell>++</cell><cell></cell><cell></cell></row><row><cell>Charles et al 34</cell><cell>Asthma</cell><cell>ERD</cell><cell>High</cell><cell>++</cell><cell></cell><cell></cell></row><row><cell>Andrade et al 36</cell><cell>HIV</cell><cell>ERD</cell><cell>High</cell><cell>+</cell><cell>e</cell><cell></cell></row><row><cell>Ho et al 33</cell><cell>Glaucoma</cell><cell>ERD</cell><cell>Low</cell><cell>++</cell><cell></cell><cell></cell></row><row><cell>Santschi et al 35</cell><cell>Hypertension</cell><cell>ERD</cell><cell>Low</cell><cell>e</cell><cell></cell><cell></cell></row><row><cell>Da Costa et al 37</cell><cell>Hypertension</cell><cell>ERD</cell><cell>Low</cell><cell></cell><cell></cell><cell>++</cell></row><row><cell>Laster et al 38</cell><cell>Glaucoma</cell><cell>ERD</cell><cell>Low</cell><cell></cell><cell>++</cell><cell>++y</cell></row><row><cell>Safren et al 40</cell><cell>HIV</cell><cell>pager</cell><cell>Low</cell><cell>++</cell><cell></cell><cell></cell></row></table><note xml:id="_xGm5zPE"><p><s xml:id="_eHXpC6f">*</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 4</head><label>4</label><figDesc><div><p xml:id="_7psZFZW"><s xml:id="_eYPYYms">Characteristics and effectiveness of interventions with a long-term follow-up period ($6 months)</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Long-term effect* on adherence measured</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>with:</cell><cell></cell></row><row><cell>Study</cell><cell>Medication for</cell><cell>Type of reminder</cell><cell>Study quality</cell><cell>Electronic monitoring</cell><cell>Self-report</cell></row><row><cell>Pop-Eleches et al 29</cell><cell>HIV</cell><cell>SMS</cell><cell>High</cell><cell>++</cell><cell></cell></row><row><cell>Simoni et al 39</cell><cell>HIV</cell><cell>Pager</cell><cell>High</cell><cell>e</cell><cell>e</cell></row><row><cell>Christensen et al 32</cell><cell>Hypertension</cell><cell>ERD</cell><cell>Low</cell><cell>e</cell><cell>e</cell></row></table><note xml:id="_ftgyPhN"><p><s xml:id="_8XvHEP6">*++¼ Overall effect; + ¼ subgroup effect; e ¼ no effect.</s><s xml:id="_rf6vndC">ERD, electronic reminder device; SMS, short message service.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_PEfGgkn"><s xml:id="_2Fv94XK">J Am Med Inform Assoc 2012;19:696e704.</s><s xml:id="_gaxtAmB">doi:10.1136/amiajnl-2011-000748</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_rfQ7D9S"><s xml:id="_3vSDpXk">J Am Med Inform Assoc 2012;19:696e704.</s><s xml:id="_9xNN8q7">doi:10.1136/amiajnl-2011-000748</s></p></note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_g2jZXJh">Competing interests None.</head><p xml:id="_JYRvDx5"><s xml:id="_ffrCeek">Provenance and peer review Not commissioned; externally peer reviewed.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<author>
			<persName><forename type="first">´e</forename><surname>Sabate</surname></persName>
		</author>
		<title level="m" xml:id="_Y4Bd47B">Adherence to Long-term Therapies. Evidence for Action</title>
		<meeting><address><addrLine>Geneva</addrLine></address></meeting>
		<imprint>
			<publisher>World Health Organization</publisher>
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sabate ´E. Adherence to Long-term Therapies. Evidence for Action. Geneva: World Health Organization, 2003.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_vWy2pBD">Variations in patients&apos; adherence to medical recommendations: a quantitative review of 50 years of research</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Dimatteo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Jfvk5c8">Med Care</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="200" to="e209" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">DiMatteo MR. Variations in patients&apos; adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004;42:200e9.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_PaMfnJS">Impact of medication adherence on hospitalization risk and healthcare cost</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Sokol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Mcguigan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Verbrugge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4gPGmxk">Med Care</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="521" to="e530" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521e30.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_d2Nwe4p">A meta-analysis of the association between adherence to drug therapy and mortality</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Eurich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Majumdar</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.38875.675486.55</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uf5upuZ">BMJ</title>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="page">15</biblScope>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006;333:15.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_xCSgMSu">Medication adherence leads to lower health care use and costs despite increased drug spending</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Roebuck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Liberman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gemmill-Toyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rrecKpE">Health Aff (Millwood)</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="91" to="e99" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Roebuck MC, Liberman JN, Gemmill-Toyama M, et al. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood) 2011;30:91e9.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_KuASD3P">Interventions for enhancing medication adherence</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Haynes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ackloo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sahota</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ud7DCZ7">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008;(2):CD000011.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_3nsX7xe">Furthering patient adherence: a position paper of the international expert forum on patient adherence based on an internet forum discussion</title>
		<author>
			<persName><forename type="first">S</forename><surname>Van Dulmen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sluijs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Van Dijk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gg8FQzG">BMC Health Serv Res</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">47</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">van Dulmen S, Sluijs E, van Dijk L, et al. Furthering patient adherence: a position paper of the international expert forum on patient adherence based on an internet forum discussion. BMC Health Serv Res 2008;8:47.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_AzHyDMR">Intentional and unintentional nonadherence: a study of decision making</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Wroe</surname></persName>
		</author>
		<idno type="DOI">10.1023/a:1015866415552</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RbTS5uP">J Behav Med</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="355" to="e72" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wroe AL. Intentional and unintentional nonadherence: a study of decision making. J Behav Med 2002;25:355e72.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_ku9EXcd">Barriers to medication adherence in poorly controlled diabetes mellitus</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Odegard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Gray</surname></persName>
		</author>
		<idno type="DOI">10.1177/0145721708320558</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qmR9CYn">Diabetes Educ</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="692" to="e697" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ 2008;34:692e7.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_SWrcAns">Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Molitch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Kramer</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc06-0454</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3D7GxVz">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1997" to="e2002" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Walker EA, Molitch M, Kramer MK, et al. Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program. Diabetes Care 2006;29:1997e2002.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_YYCWFPT">Addressing the challenges of adherence</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Bartlett</surname></persName>
		</author>
		<idno type="DOI">10.1097/00126334-200202011-00002</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fJ67VN5">J Acquir Immune Defic Syndr</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">Suppl 1</biblScope>
			<biblScope unit="page" from="2" to="e10" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr 2002;29(Suppl 1):S2e10.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_S5DxXjS">Barriers to and facilitators of HIV-positive patients&apos; adherence to antiretroviral treatment regimens</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Roberts</surname></persName>
		</author>
		<idno type="DOI">10.1089/108729100317948</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bRbvYcZ">AIDS Patient Care STDS</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="155" to="e68" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Roberts KJ. Barriers to and facilitators of HIV-positive patients&apos; adherence to antiretroviral treatment regimens. AIDS Patient Care STDS 2000;14:155e68.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_V2ZUM4J">Medication adherence in patients who have heart failure: a review of the literature</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Moser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Lennie</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cnur.2007.10.006</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WA7DNvN">Nurs Clin North Am</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="133" to="e53" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wu JR, Moser DK, Lennie TA, et al. Medication adherence in patients who have heart failure: a review of the literature. Nurs Clin North Am 2008; 43:133e53.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_jWFfn2B">Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Nair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Belletti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Doyle</surname></persName>
		</author>
		<idno type="DOI">10.2147/ppa.s18481</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AnvsSsG">Patient Prefer Adherence</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="195" to="e206" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nair KV, Belletti DA, Doyle JJ, et al. Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey. Patient Prefer Adherence 2011;5:195e206.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_AjNM6DS">Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Olthoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Hoevenaars</surname></persName>
		</author>
		<author>
			<persName><surname>Van Den Borne</surname></persName>
		</author>
		<author>
			<persName><surname>Bw</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cxcvsWV">Graefes Arch Clin Exp Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">247</biblScope>
			<biblScope unit="page" from="235" to="e243" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Olthoff CM, Hoevenaars JG, van den Borne BW, et al. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients. Graefes Arch Clin Exp Ophthalmol 2009;247:235e43.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_CVSg5WV">Barriers to adherence in adolescents and young adults with cystic fibrosis: a questionnaire study in young patients and their parents</title>
		<author>
			<persName><forename type="first">V</forename><surname>Bregnballe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">O</forename><surname>Schiotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Boisen</surname></persName>
		</author>
		<idno type="DOI">10.2147/ppa.s25308</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7K4BbWq">Patient Prefer Adherence</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="507" to="e515" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bregnballe V, Schiotz PO, Boisen KA, et al. Barriers to adherence in adolescents and young adults with cystic fibrosis: a questionnaire study in young patients and their parents. Patient Prefer Adherence 2011;5:507e15.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_8a5HxfV">Self-management skills in adolescents with chronic rheumatic disease: a cross-sectional survey</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Lawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">O</forename><surname>Hersh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Applebaum</surname></persName>
		</author>
		<idno type="DOI">10.1186/1546-0096-9-35</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DS4ZKXm">Pediatr Rheumatol Online J</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">35</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lawson EF, Hersh AO, Applebaum MA, et al. Self-management skills in adolescents with chronic rheumatic disease: a cross-sectional survey. Pediatr Rheumatol Online J 2011;9:35.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_ZbD9sWc">Perceived barriers to adherence among adolescent renal transplant candidates</title>
		<author>
			<persName><forename type="first">N</forename><surname>Zelikovsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Schast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Palmer</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1399-3046.2007.00886.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DcfpRxR">Pediatr Transplant</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="300" to="e308" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zelikovsky N, Schast AP, Palmer J, et al. Perceived barriers to adherence among adolescent renal transplant candidates. Pediatr Transplant 2008;12:300e8.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_Y3yD74r">Reminder packaging for improving adherence to self-administered long-term medications</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Mahtani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Heneghan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Glasziou</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd005025.pub3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KufFwNz">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">5025</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mahtani KR, Heneghan CJ, Glasziou PP, et al. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev 2011;(9):CD005025.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_ywjJhu2">Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Zedler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kakad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Colilla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Qm9Khmw">Clin Ther</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="62" to="e73" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zedler BK, Kakad P, Colilla S, et al. Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review. Clin Ther 2011;33:62e73.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_btEvDrb">Efficacy of telephone and mail intervention in patient compliance with antihypertensive drugs in hypertension. ETECUMeHTA study</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Marquez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">O</forename><surname>Vegazo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Claros</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RSMAaTk">Blood Press</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="151" to="e158" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Marquez CE, Vegazo GO, Claros NM, et al. Efficacy of telephone and mail intervention in patient compliance with antihypertensive drugs in hypertension. ETECUMeHTA study. Blood Press 2005;14:151e8.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_jp7HzAm">A telephone-based intervention for increasing the use of osteoporosis medication: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Waalen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Bruning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Peters</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kzTVasz">Am J Manag Care</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="60" to="e70" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Waalen J, Bruning AL, Peters MJ, et al. A telephone-based intervention for increasing the use of osteoporosis medication: a randomized controlled trial. Am J Manag Care 2009;15:e60e70.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_RhxafgZ">Behavioral theories and the problem of compliance</title>
		<author>
			<persName><forename type="first">H</forename><surname>Leventhal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cameron</surname></persName>
		</author>
		<idno type="DOI">10.1016/0738-3991(87)90093-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5ndebHT">Patient Educ Couns</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="117" to="e138" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Leventhal H, Cameron L. Behavioral theories and the problem of compliance. Patient Educ Couns 1987;10:117e38.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_THFyZXM">Interventions for improving adherence to ocular hypotensive therapy</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Orton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Henson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Q234Bba">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">6132</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gray TA, Orton LC, Henson D, et al. Interventions for improving adherence to ocular hypotensive therapy. Cochrane Database Syst Rev 2009;(2):CD006132.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_5mKE9xK">Use of electronic reminder devices to improve adherence to antiretroviral therapy: a systematic review</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Operario</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Xq22cYr">AIDS Patient Care STDS</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="495" to="e504" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wise J, Operario D. Use of electronic reminder devices to improve adherence to antiretroviral therapy: a systematic review. AIDS Patient Care STDS 2008;22:495e504.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_hnURJzA">Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Misono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Cutrona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Choudhry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_X2BBs7x">Am J Manag Care</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="82" to="e92" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>Suppl HIT</note>
	<note type="raw_reference">Misono AS, Cutrona SL, Choudhry NK, et al. Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence. Am J Manag Care 2010;16(12 Suppl HIT):SP82e92.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title level="m" type="main" xml:id="_eRfDD4Y">Cochrane Handbook for Systematic Reviews of Interventions Version 5</title>
		<author>
			<persName><forename type="first">Jpt</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Green</surname></persName>
		</author>
		<ptr target="http://www.cochrane-handbook.org" />
		<imprint>
			<date type="published" when="2011-03">March 2011. 2011. November 2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. 2011. http://www.cochrane- handbook.org (accessed November 2011).</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_uR6E7Ed">Randomized controlled trial of a personalized cellular phone reminder system to Enhance adherence to antiretroviral therapy</title>
		<author>
			<persName><forename type="first">H</forename><surname>Hardy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Doros</surname></persName>
		</author>
		<idno type="DOI">10.1089/apc.2010.0006</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Ub3pNrP">AIDS Patient Care STDS</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="153" to="e61" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hardy H, Kumar V, Doros G, et al. Randomized controlled trial of a personalized cellular phone reminder system to Enhance adherence to antiretroviral therapy. AIDS Patient Care STDS 2011;25:153e61.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_anWcz2D">Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders</title>
		<author>
			<persName><forename type="first">C</forename><surname>Pop-Eleches</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Thirumurthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Habyarimana</surname></persName>
		</author>
		<idno type="DOI">10.1097/qad.0b013e32834380c1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uPDU9EN">AIDS</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="825" to="e834" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS 2011;25:825e34.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_MR4Qt29">Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hurwitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kavanagh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rUazHm7">Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="633" to="e640" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hou MY, Hurwitz S, Kavanagh E, et al. Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial. Obstet Gynecol 2010;116:633e40.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_2yNHdJp">A daily SMS reminder increases adherence to asthma treatment: a three-month follow-up study</title>
		<author>
			<persName><forename type="first">U</forename><surname>Strandbygaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Thomsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Backer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2FqhzHG">Respir Med</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="166" to="e71" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Strandbygaard U, Thomsen SF, Backer V. A daily SMS reminder increases adherence to asthma treatment: a three-month follow-up study. Respir Med 2010;104:166e71.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_KchQRS8">The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Christensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Christrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Fabricius</surname></persName>
		</author>
		<idno type="DOI">10.1097/hjh.0b013e328331b718</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ujgChDN">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="194" to="e200" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Christensen A, Christrup LL, Fabricius PE, et al. The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: a randomized controlled trial. J Hypertens 2010;28:194e200.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_Wp3kpgj">Effect of audible and visual reminders on adherence in glaucoma patients using a commercially available dosing aid</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Y</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Camejo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Kahook</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4f4Bjvp">Clin Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="769" to="e72" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ho LY, Camejo L, Kahook MY, et al. Effect of audible and visual reminders on adherence in glaucoma patients using a commercially available dosing aid. Clin Ophthalmol 2008;2:769e72.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_ckjEHPv">An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma</title>
		<author>
			<persName><forename type="first">T</forename><surname>Charles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Weatherall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cMf4cVx">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="811" to="e816" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Charles T, Quinn D, Weatherall M, et al. An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. J Allergy Clin Immunol 2007;119:811e16.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_KfkTMab">Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring</title>
		<author>
			<persName><forename type="first">V</forename><surname>Santschi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wuerzner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Schneider</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Vz3unBb">Eur J Clin Pharmacol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="1179" to="1e84" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Santschi V, Wuerzner G, Schneider MP, et al. Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring. Eur J Clin Pharmacol 2007;63:1179e84.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_p8zqPD3">A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Andrade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Mcgruder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MscJuCn">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="875" to="e82" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Andrade AS, McGruder HF, Wu AW, et al. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clin Infect Dis 2005;41:875e82.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_vTmfaCK">Effect of reminder cards on compliance with antihypertensive medication</title>
		<author>
			<persName><forename type="first">Da</forename><surname>Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Guerreiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Nunes</forename><surname>De Melo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NZMawPs">Int J Pharm Pract</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="205" to="e211" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Da Costa FA, Guerreiro JP, Nunes De Melo M, et al. Effect of reminder cards on compliance with antihypertensive medication. Int J Pharm Pract 2005;13:205e11.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_zKFxwyz">The effect of a medication alarm device on patient compliance with topical pilocarpine</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Laster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Fleming</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tfBmkZC">J Am Optom Assoc</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="654" to="e658" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Laster SF, Martin JL, Fleming JB. The effect of a medication alarm device on patient compliance with topical pilocarpine. J Am Optom Assoc 1996;67:654e8.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_yV467cv">Peer support and pager messaging to promote antiretroviral modifying therapy in seattle. A randomized controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Simoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Huh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Frick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_G55HGEa">J Acquired Immune Defic Syndr</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="465" to="e73" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Simoni JM, Huh D, Frick PA, et al. Peer support and pager messaging to promote antiretroviral modifying therapy in seattle. A randomized controlled trial. J Acquired Immune Defic Syndr 2009;52:465e73.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_YjDShW3">Use of an on-line pager system to increase adherence to antiretroviral medications</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Safren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Hendriksen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Desousa</surname></persName>
		</author>
		<idno type="DOI">10.1080/09540120310001618630</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ApVwvQH">AIDS Care</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="787" to="e93" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Safren SA, Hendriksen ES, Desousa N, et al. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care 2003;15:787e93.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_ctdAk9y">Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Van Tulder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Furlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bombardier</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.brs.0000065484.95996.af</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VhKbDtZ">Spine (Phila Pa</title>
		<imprint>
			<biblScope unit="volume">197</biblScope>
			<biblScope unit="page" from="1290" to="e1299" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">van Tulder TM, Furlan A, Bombardier C, et al. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine (Phila Pa 197) 2003;28:1290e9.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_xerUexs">Occupational therapy for multiple sclerosis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Steultjens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dekker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Bouter</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd003608</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aXtM9RG">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">3608</biblScope>
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Steultjens EM, Dekker J, Bouter LM, et al. Occupational therapy for multiple sclerosis. Cochrane Database Syst Rev 2003;(3):CD003608.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_Ku8vxr6">Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories</title>
		<author>
			<persName><forename type="first">B</forename><surname>Vrijens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vincze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kristanto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_K5TxmJA">BMJ</title>
		<imprint>
			<biblScope unit="volume">336</biblScope>
			<biblScope unit="page" from="1114" to="e1117" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008;336:1114e17.</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_FTfd69J">Real-time adherence monitoring for HIV antiretroviral therapy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Haberer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kahane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kigozi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yNRxcYZ">AIDS Behav</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1340" to="e1346" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Haberer JE, Kahane J, Kigozi I, et al. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav 2010;14:1340e6.</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_DGcu2UT">Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Haberer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Robbins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ybarra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wzUC8PU">AIDS Behav</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="375" to="e82" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Haberer JE, Robbins GK, Ybarra M, et al. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav 2012;16:375e82.</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_XVAFzVS">Improving medication adherence in diabetes type 2 patients through real time medication monitoring: a randomised controlled trial to evaluate the effect of monitoring patients&apos; medication use combined with short message service (SMS) reminders</title>
		<author>
			<persName><forename type="first">M</forename><surname>Vervloet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Van Dijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Santen-Reestman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vMczrSf">BMC Health Serv Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">5</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vervloet M, van Dijk L, Santen-Reestman J, et al. Improving medication adherence in diabetes type 2 patients through real time medication monitoring: a randomised controlled trial to evaluate the effect of monitoring patients&apos; medication use combined with short message service (SMS) reminders. BMC Health Serv Res 2011;11:5.</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_B4yDyee">Survey of patient and physician assessment of a compliance reminder device in the treatment of hypertension</title>
		<author>
			<persName><forename type="first">A</forename><surname>Christensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Christrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Fabricius</surname></persName>
		</author>
		<idno type="DOI">10.3109/08037050903289598</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nPuKrM8">Blood Press</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="280" to="e285" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Christensen A, Christrup LL, Fabricius PE, et al. Survey of patient and physician assessment of a compliance reminder device in the treatment of hypertension. Blood Press 2009;18:280e5.</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_7RzQKw9">Electronic reminders to improve medication adherence e are they acceptable to the patient?</title>
		<author>
			<persName><forename type="first">L</forename><surname>Sahm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Maccurtain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hayden</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11096-009-9327-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wR6zCpg">Pharm World Sci</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="627" to="e629" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sahm L, MacCurtain A, Hayden J, et al. Electronic reminders to improve medication adherence e are they acceptable to the patient? Pharm World Sci 2009;31:627e9.</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_ddSeuS5">Tailored and targeted health communication: strategies for enhancing information relevance</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Kreuter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Wray</surname></persName>
		</author>
		<idno type="DOI">10.5993/ajhb.27.1.s3.6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_w6uVZnF">Am J Health Behav</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">Suppl 3</biblScope>
			<biblScope unit="page" from="227" to="e232" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kreuter MW, Wray RJ. Tailored and targeted health communication: strategies for enhancing information relevance. Am J Health Behav 2003;27(Suppl 3):S227e32.</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_9nbc7Fj">A text message programme designed to modify patients&apos; illness and treatment beliefs improves self-reported adherence to asthma preventer medication</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Petrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Broadbent</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.2044-8287.2011.02033.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hf9KRJX">Br J Health Psychol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="74" to="e84" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Petrie KJ, Perry K, Broadbent E, et al. A text message programme designed to modify patients&apos; illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br J Health Psychol 2012;17:74e84.</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_t2t7qM2">Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging</title>
		<author>
			<persName><forename type="first">T</forename><surname>Miloh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Annunziato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Arnon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_N5tuZUn">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="844" to="e50" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Miloh T, Annunziato R, Arnon R, et al. Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging. Pediatrics 2009;124: e844e50.</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_nsWHr8x">Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Farmer</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0149-2918(99)80026-5</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fssqFyq">Clin Ther</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="1074" to="1e90" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999;21:1074e90.</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_UsRRZZu">Adherence to medication</title>
		<author>
			<persName><forename type="first">L</forename><surname>Osterberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Blaschke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tYJEnBP">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">353</biblScope>
			<biblScope unit="page" from="487" to="e97" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487e97.</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_ZnXS7up">A preliminary randomized controlled trial of a nurse-delivered medication adherence intervention among HIV-positive outpatients initiating antiretroviral therapy in Beijing, China</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Simoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Huh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WCUs934">AIDS Behav</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="919" to="e929" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Simoni JM, Chen WT, Huh D, et al. A preliminary randomized controlled trial of a nurse-delivered medication adherence intervention among HIV-positive outpatients initiating antiretroviral therapy in Beijing, China. AIDS Behav 2011;15:919e29.</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_VMw4tdX">Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE</title>
		<author>
			<persName><forename type="first">R</forename><surname>Dusing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Handrock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Klebs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xrhM7Fn">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="894" to="e901" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dusing R, Handrock R, Klebs S, et al. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE. J Hypertens 2009;27:894e901.</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_AbVhkcv">Randomized trial of an adherence programme for clients with HIV</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Fairley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Rayner</surname></persName>
		</author>
		<idno type="DOI">10.1258/095646203322556129</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ty5pyVW">Int J STD AIDS</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="805" to="e809" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fairley CK, Levy R, Rayner CR, et al. Randomized trial of an adherence programme for clients with HIV. Int J STD AIDS 2003;14:805e9.</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_Xm6U4B4">A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Franklin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Waller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pagliari</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1464-5491.2006.01989.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fDPFBYK">Diabetic Med</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1332" to="e1338" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Franklin VL, Waller A, Pagliari C, et al. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabetic Med 2006;23:1332e8.</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_G4ZNFaQ">Antiretroviral medication adherence and persistence with respect to adherence tool usage</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Ostrop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Gill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tXY3Ecd">AIDS Patient Care and STDs</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="351" to="e358" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ostrop NJ, Gill MJ. Antiretroviral medication adherence and persistence with respect to adherence tool usage. AIDS Patient Care and STDs 2000;14:351e8.</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_mdzBk3h">Good and poor adherence: optimal cut-point for adherence measures using administrative claims data</title>
		<author>
			<persName><forename type="first">S</forename><surname>Karve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Cleves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Helm</surname></persName>
		</author>
		<idno type="DOI">10.1185/03007990903126833</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8mbmQdN">Curr Med Res Opin</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="2303" to="e2310" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Karve S, Cleves MA, Helm M, et al. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 2009;25:2303e10.</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_3Xxpsz5">Oral antidiabetic medication adherence and glycemic control in managed care</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Rozenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Hunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Plauschinat</surname></persName>
		</author>
		<idno type="DOI">10.37765/ajmc.2020.44073</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Edx4MKJ">Am J Manag Care</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">75</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PAGE fraction trail=8</note>
	<note type="raw_reference">Rozenfeld Y, Hunt JS, Plauschinat C, et al. Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care 2008;14:71e5. PAGE fraction trail=8.75</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
